ArticleNeurosurgery2026
Early Initiation of Radiation Therapy Improves Survival in Elderly Patients With Glioblastoma.
Article in Neurosurgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesTo study the impact of early initiation of radiation therapy (RT) in elderly patients with newly diagnosed glioblastoma.
methodsA total of 56 elderly patients (aged 65 and older) diagnosed with isocitrate dehydrogenase (IDH)-wildtype glioblastoma were analyzed from a prospective registry from 2020 to 2024. Survival analysis was conducted to evaluate the impact of timing of RT initiation after surgical resection on survival outcomes. A specific cutoff point for RT initiation was evaluated using the log-rank test, with P -values adjustment for multiple comparisons using the false discovery rate approach. Kaplan-Meier curves were used to illustrate survival distributions. Associations of various risk factors with survival were initially examined through univariate Cox regression models, followed by multivariate analysis to assess the combined effects of these factors. The results were reported as hazard ratios with 95% CIs.
resultsElderly patients with glioblastoma who underwent initiation of RT < 20 days from date of surgery demonstrated improved overall survival (OS) ( P = .0460) and progression-free survival (PFS) ( P = .0075) in our cohort. Multivariate analysis demonstrated that adjuvant temozolomide significantly affected both OS ( P = .0038) and PFS ( P = .0133). Conventionally fractionated RT consisting of 60 Gy in 30 fractions demonstrated significantly improved PFS ( P = .0164) in patients who underwent early initiation of RT (<20 days). By contrast, hypofractionated RT delivering 40 Gy in 15 fractions did not show significantly improved PFS ( P = .0509) in patients who underwent early initiation of RT (<20 days).
conclusionEarly initiation of RT in elderly patients with newly diagnosed glioblastoma improves both OS and progression-free survival. Timing of RT is particularly of significance in this patient population who may not be optimal candidates for systemic chemotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.